10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,821,907 | -45.0% | 189,622 | -25.5% | 0.00% | -40.0% |
| Q2 2023 | $14,218,986 | +99208.5% | 254,638 | -0.8% | 0.01% | 0.0% |
| Q1 2023 | $14,318 | +79.1% | 256,636 | +17.0% | 0.01% | +66.7% |
| Q4 2022 | $7,993 | -99.9% | 219,338 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $6,404,000 | -39.7% | 224,871 | -4.2% | 0.00% | -25.0% |
| Q2 2022 | $10,621,000 | -21.8% | 234,701 | +15.1% | 0.00% | 0.0% |
| Q1 2022 | $13,575,000 | -53.5% | 203,917 | +4.0% | 0.00% | -55.6% |
| Q4 2021 | $29,207,000 | -2.7% | 196,072 | -4.9% | 0.01% | 0.0% |
| Q3 2021 | $30,009,000 | -76.6% | 206,130 | -69.4% | 0.01% | -76.3% |
| Q2 2021 | $128,387,000 | -32.4% | 674,419 | -35.8% | 0.04% | -36.7% |
| Q1 2021 | $190,000,000 | +24.2% | 1,049,726 | -2.9% | 0.06% | +15.4% |
| Q4 2020 | $153,034,000 | +22.6% | 1,080,745 | +7.9% | 0.05% | +8.3% |
| Q3 2020 | $124,856,000 | +360.7% | 1,001,406 | +212.8% | 0.05% | +336.4% |
| Q2 2020 | $27,101,000 | – | 320,156 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |